We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 0% above its sector, the market expects faster growth.
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, outsources, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, lithotripsy, and stents. It also provides consulting services related to the construction of nursing care facilities, M&A, and support to medical and nursing care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reservations, posting agency for customer satisfaction surveys, and network security systems sales. In addition, the company offers network integration and software design and development; equipment used in physical therapy and rehabilitation, as well as related consumables such as surgical gowns, gloves, and bandages; manufactures and sells medical devices, and conduct contract research on medical ultrasound, as well as the development, sales, and consulting of medical devices and peripheral devices that use ultrasound. Yamashita Health Care Holdings,Inc. was founded in 1926 and is based in Fukuoka City, Japan.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 9265.T and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
